Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Mithra enters license and supply agreement with Fuji Pharma for Donesta

June 29, 2017

New GPR40 agonist ID-11014A shows preclinical liver safety and effects on glucose tolerance

June 29, 2017

Phase I study of KL-1333 begins

June 28, 2017

SP-1373 has beneficial effects on body and liver weight in obesity models

June 28, 2017

FDA confirms regulatory pathway to approval for bempedoic acid/ezetimibe

June 28, 2017

Merck & Co. discloses leukotriene BLT1 receptor antagonists

June 27, 2017

Centro de Investigacion Biomedica en Red and collaborators divulge AMPK activators

June 27, 2017

Heinrich-Heine-Universitaet Duesseldorf patents NMDA receptor antagonists

June 27, 2017

Rhythm and Camurus report initial phase Ia results on extended-release setmelanotide

June 27, 2017

FDA awards fast track designation to Synlogic's SYNB-1020

June 27, 2017

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...